COVID-19 Ocular Manifestation: A Cross-Sectional Study

Author:

Hussein Ali Ramadhan ,Abdullah A. Qadir ,Roza E. Mirdan ,Harem K. Ahmed ,Imad J. Habibullah ,Karukh K. Mohammed ,Berun A. Abdalla ,Fahmi H. Kakamad ,Shvan H. Mohammed ,Sabah Jalal Hasan ,Fakher Abdullah

Abstract

Introduction The world is infected with a new strain of the coronavirus family known as COVID-19. This virus strain attacked several organs in the human body, causing symptoms ranging from mild to severe and, in some cases, life-threatening. Multiple organs, including the eye, can get infected. Methods The study was a single-center prospective cross-sectional study that included patients with a recent COVID-19 infection. The study was conducted in the ophthalmology department of Erbil Teaching Hospital in Erbil City from June 2021 to April 2022. The participants were recruited from the outpatient clinic in a non-probability convenience sampling way. Results The study included 75 patients. The most common ocular disease encountered in COVID-19 patients was posterior subcapsular cataract (12, 16.0%). Their ages are between 26 and 56 years old. The cataract developed in twelve patients (12, 16.0%), and it was bilateral in nine cases (18 eyes) with a varying degree of density. The next most common manifestation was multiple punctate epitheliopathy found in nine patients, which was bilateral in all of them. Follicular conjunctivitis was encountered in eight patients; it resolved in a period of 5 to 8 days after the prescription of topical anti-inflammatory medications. Conclusion COVID-19 infection is a multi-systemic disease that can cause a variety of ocular clinical symptoms and complications. Blurred vision and conjunctivitis-like features are the most common ocular presentations of the infection.

Publisher

Barw Medical Journal

Reference35 articles.

1. COVID-19 background primer for ophthalmologists. American Academy of Ophthalmology. 2020. Available from: https://www.aao.org/headline/covid-19-background-primer-ophthalmologists

2. World Health Organization. Coronavirus disease (COVID-19). World Health Organization. 2020. Availablefrom: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19

3. CDC. COVID-19. Centers for Disease Control and Prevention. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/index.html

4. Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomedical Journal. 2020;43(4):328–33. doi:10.1016/j.bj.2020.04.007

5. Aso S. Muhialdeen, Jaafar Omer Ahmed, Hiwa O. Baba, Ismael Y. Abdullah, Hemn Ali Hassan, Kayhan A. Najar, et al. Kscien’s List; A New Strategy to Discourage Predatory Journals and Publishers (Second Version). Barw Medical Journal. 2023;1(1) doi:10.58742/bmj.v1i1.14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3